Oruka Therapeutics, Inc. Other Current Assets
Oruka Therapeutics, Inc. (ORKA) had Other Current Assets of $537.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-08-01
- 2024-06-30: Other Assets, Current $537.00K.
- 2024-03-31: Other Assets, Current $767.00K.
- 2023-12-31: Other Assets, Current $161.00K.
- 2023-09-30: Other Assets, Current $405.00K.
| Period end | Other Assets, Current |
|---|---|
| 2024-06-30 | $537.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $767.00K 10-Q · filed 2024-04-25 |
| 2023-12-31 | $161.00K 10-Q · filed 2024-08-01 |
| 2023-09-30 | $405.00K 10-Q · filed 2023-10-18 |
| 2023-06-30 | $599.00K 10-Q · filed 2023-07-21 |
| 2023-03-31 | $852.00K 10-Q · filed 2023-04-24 |
| 2022-12-31 | $254.00K 10-K · filed 2024-02-01 |
| 2022-09-30 | $611.00K 10-Q · filed 2022-10-28 |
| 2022-06-30 | $1.22M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $1.48M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $1.06M 10-K · filed 2023-02-24 |
| 2021-09-30 | $1.35M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.60M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.80M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $897.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $841.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $532.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $704.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $117.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $259.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $357.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $513.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $169.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $336.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $375.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $631.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $547.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $425.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $648.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $643.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $282.00K 10-K · filed 2018-03-22 |
| 2016-09-30 | $320.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $377.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $391.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $114.00K 10-K · filed 2017-03-21 |
| 2015-09-30 | $205.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $241.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $490.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $134.00K 10-K · filed 2016-03-17 |
| 2014-09-30 | $216.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $303.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $599.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $169.00K 10-K · filed 2015-03-19 |
| 2013-09-30 | $379.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $284.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $456.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $125.00K 10-K · filed 2014-03-20 |
| 2012-09-30 | $184.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $408.00K 10-Q · filed 2012-08-13 |
| 2012-03-31 | $475.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $269.00K 10-K · filed 2013-03-21 |
| 2011-09-30 | $340.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $364.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $137.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |